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The Sickle-cell Phenomenon
B Y
I’ ETKH BRAIN. M . D . .  b . s c .
Department a j  Pathology, L niver.sity o f  
C ape Town.
Tilt' sickle-cell phenomenon is an inherited 
peculiarity of the red blood cells, by virtue of 
which, when oxygen is withdrawn, the cells 
asume elongated or crescent shapes somewhal 
resembling sickles. Clinically, those whose red 
cells show the sickling anomaly fall roughly into 
two classes:—
la.) Bearers of the sickle-cell trait, a symp­
tomless condition in which no sickled cells are 
found in the circulating blood, but in which 
sickling can be produced by artificially reducing 
t i.e.. deoxygenating I the haemoglobin.
lb I Patients with sickle-cell disease. There are 
two main pathological manifestations of sickling, 
which may appear together in the same patient 
or separately. These are 11) sickle-cell anaemia, 
a haemolytic anaemia characterised by the 
appearance of sickled cells in the peripheral 
blood; and (2) vascular complications due to 
the blocking of small vessels by masses of sickled 
erythrocytes. This may lead to infarction of 
various organs with results such as haematuria. 
hemiplegia or sudden death- -the sickling crisis, 
ft has been suggested 1 that the haemolysis in 
sickle-cell anaemia may be due to the disin­
tegration of masses of sickled cells which have 
become impacted in small vessels, perhaps by 
reason of their shape. This would mean that 
the primary lesion in sickle-cell disease was 
always one of vascular occlusion, but the view 
is not universally accepted. Gelfand 40 has 
described a case of sickle-cell anaemia from 
Southern Khodesia, and I shall say no more on 
the clinical features of this disease. The vascular 
manifestations of sickling will be considered 
later.
Sickle-cell anaemia was first recognised in 
1910 by Herrick in an American negro student." 
For some years sickling was sought in the ordin­
ary smear taken from the peripheral blood, and 
thus the existence of the trait was not recognised. 
In 1921 Hahn and Gillespie3 showed that 
sickling occurred when the haemoglobin in 
susceptible cells was in the reduced state. When 
means of reducing the haemoglobin were ap­
plied to the cells of apparently normal Ameri­
can negroes, it was found that a proportion
showed sickling who did not develop the anaemia 
or show1 other signs of disease. These were the 
trait-bearers. 'Pile incidence of the trait in 
American negroes is on the average about f> per 
cent.4
Several methods have been used to elicit 
sickling. In the classical one a drop of blood 
is sealed under a coverslip with vaseline.•’ The 
slide is examined with the microscope at inter­
vals. The activities of the white and young red 
cells gradually remove oxygen from the blood 
and sickling usually appears within 24 hours in 
trait-bearers: in sickle-cell anaemia it begins 
much sooner. More efficient methods, using 
chemical reducing agents, are now available. 
Daland and Castle6 use a 2 per cent, aqueous 
solution of sodium metabisulphite, Na^S^05- 
A drop of blood is mixed on a slide with a drop 
of this reagent, which should be freshly pre­
pared. Sickling appears in five minutes or less.
No matter what method is used to elicit it, 
sickling appears far more rapidly in tile blood 
of patients with sickle-cell anaemia than in trait- 
bearers. In the anaemia also the sickled cells 
have long filamentous processes not seen in the 
trait. It has been shown that the reduction of 
oxygen tension necessary to elicit sickling is 
less in the anaemia than in the trait, which 
accounts for the more rapid sickling in the blood 
of patients with the anaemia and for the ap­
pearance of sickled cells in vivo. In the sickle­
cell trait the haemoglobin has to be deoxygenated 
beyond physiological limits before sickling will 
occur.
In 1949 Pauling and his colleagues’ showed 
that in subjects with the sickle-cell anomaly an 
abnormal haemoglobin is present in the red 
cells. This haemoglobin was identified by its 
electrophoretic mobility— that is, by its rate of 
migration in an electric field. It differs from 
normal haemoglobin also in being very in­
soluble when reduced, and it is the crystallisation 
of the abnormal haemoglobin inside the cell 
which accounts for the sickled shape when 
oxygen tension is reduced. It was shown that 
in sickle-cell anaemia all or nearly all of the 
haemoglobin was of the abnormal variety, now 
known as haemoglobin S. In bearers of the 
sickle-cell trait haemoglobin S represents about 
40 per cent, of the total, the rest being normal.
It had been known for a long time that 
sickling was inherited as a Mendelian dominant 
character. In 1949 Neel 8 in America and Beet9 
in Northern Rhodesia suggested independently
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that sickle-cull anaemia was a manifestation of 
homozygosity for the sickling gene— that is, that 
for a patient to develop sickle-cell anaemia he 
must possess a pair of sickling genes, One derived 
from each of his parents. Those who were 
heterozygous--that is, who had only a single 
sickling gene would show the trait, but would 
not develop the anaemia. This is true as far 
as it goes, but the theory has required some 
modification. In particular it has been found 
that one sickling gene may combine with another 
gene to produce syndromes clinically resembling 
sickle-cell anaemia. Thus a patienL who receives 
a sickling gene from one parent and a gene for 
Mediterranean anaemia from the other may 
show a sickle-cell-anaemia-likc syndrome known 
as sickle-cell-thalassaemia disease.1" The sick­
ling gene may combine in the same way with 
genes producing two abnormalities of the haemo­
globin, known as haemoglobins C and D. The 
syndromes thus produced are called sickle-cell- 
haemoglobin-C and sickle-cell-haemoglobin-D 
disease.11,12,13
We have seen that in America, where sickling 
was first discovered, about 8 per cent, of the 
Negro population possess the trait. Occasional 
cases of sickling have been described in white 
Americans.1'1 Where this is not due to Negro 
ancestry it is usually found that these subjects 
are of Mediterranean descent. Sickling is not 
uncommon in parts of Greece15 and in other 
Mediterranean countries. in Africa, sickling 
is widely but patchily distributed in the black 
peoples. In West Africa, the original home of 
the American Negro, an average incidence of 
12.4 per cent, was found by Findlay cl al.16 In 
the Bantu tribes of Central, East and South 
Africa there are all degrees of sickling incidence 
from less than 1 per cent., e.g., in the Karanga 
of Southern Rhodesia,17 to 45 per cent, in the 
Raamba of Ruwenzori.111 Lehmann and Raper 18 
showed that in Uganda the incidence of sickling 
in Bantu tribes was inversely proportional to 
the extent of their recent contact with peoples 
of Hamitic (non-Negro) stock. One of the 
most remarkable features of sickling distribution 
in Africa is its rarity south of the Zambesi 
River.17,1" In Southern Rhodesia most of the 
sicklers found are immigrants from the north 
or their descendants. The tribe of highest 
incidence so far recorded in Southern Rhodesia 
is the Nclau of the Eastern Border,17 who show 
3 per cent, of sicklers. In the Union of South 
Africa the indigenous Bantu have less than 1 per 
cent, of sickling,19' 20-21 and the Bushmen 22 none 
at all. At the Zambesi River the incidence rises
sharply. The Cikunda on the river have 13 per 
cent.17 of sicklers and the Senga of Fort Jame­
son 20 per cent.2" English24 found an overall 
incidence of 17.5 per cent, among the workers 
in the copper mines of Northern Rhodesia. Fig. 
1 shows percentage incidences of sickling in 
some tribes of the Federation and adjacent terri­
tories. The general distribution of sickling in 
Africa was summarised, with a map, by an 
annotator in the Soulk African Medical Journal 
in 1952.25
We have seen that many of the African tribes 
have an incidence of the sickle-cell trait con­
siderably higher than that in the American 
Negroes. Thus we would expect sickle-cell
anaemia to be a relatively common disease in 
Africa. Many believe, however, that sickle-cell 
anaemia is by no means as common in Africa 
as it ought to be. South of the Zambesi its 
rarity is understandable, because of the very low 
incidence of the sickle-cell trait. Elsewhere, 
experienced workers such as Jelliffe26 in Nigeria 
and Lehmann 27 in Uganda have expressed doubt 
whether the anaemia occurs al the expected fre­
quency. Lehmann has brought forward evi­
dence to suggest that many homozygous sicklers 
survive in Africa without being incapacitated 
by sickle-cell anaemia. In the United States 
those who develop sickle-cell anaemia either die 
young or, if they survive, do not usually re­
produce. In Africa, where the incidence of 
sickling is in some parts five times as great as 
that in the Lnited States, such a loss of homo­
zygotes should lead to a very rapid reduction 
in sickling incidence. This does not appear to 
happen, which suggests that, as Lehmann be­
lieves, some homozygous sicklers may escape 
the disease. Other authors, however, 28-29 have 
shown that in some parts at any rate sickle-cell 
anaemia occurs at the expected frequency. The 
question is still undecided.
Until quite recently it was always assumed 
that the sickle-cell anomaly was of African 
origin, since the only other places in which it 
was found were in the New W orld, to which it 
had been conveyed by the slave trade, or in the 
Mediterranean countries which had been pene­
trated by Africans from the earliest times. When 
Lehmann and Cutbush30 discovered the trait 
in India, therefore, it was clear that ideas on 
the origin of the sickle-cell would have to be 
modified. These authors investigated the 
aboriginal hill tribes of South India, who are 
the survivors of the pre-Dravidian population. 
They are at a very primitive stage of civilisation.
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In a sample of 201 of these aborigines, 31 per 
cent, of sicklers were found. The question at 
once arose whether these Indian tribes had not 
received their sickle-cells from African sources, 
but the study of their blood groups showed that 
this was most unlikely. All black peoples in 
Africa south of the Sahara, and the Bushmen 
as well, possess a high incidence— everywhere 
over 50 per cent.—of the Rh chromosome cDe 
t Rho ). The Indian aborigines, however, showed 
a very low cDe incidence. Thus, unless they
developed their sickle-cells independently of the 
Africans, we have to consider the possibility of 
a migration which brought the sickling gene 
from India to Africa. The presence of Yeddian 
peoples, related to the Indian aborigines, in 
Persia and South Arabia lends support to this 
theory, which has been put forward by 
Lehmann.31 He suggests that the route may 
have been through South Arabia and across the 
southern end of the Red Sea, introducing the 
sickle-cell into what is now Somaliland. I have
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suggested elsewhere32 that the distribution of 
a certain breed of Indian cattle in Africa sup­
ports the view of Lehmann on the introduction 
of the sickle-cell.
When we consider the distribution of sickling 
in Africa from the point of view of the physician 
rather than that of the anthropologist, it is clear 
at once that it has some very peculiar features. 
In a tribe with a trait incidence of 10 per cent.
-and such tribes are not very uncommon—we 
would expect about 8 per cent, of all children 
born to be homozygous sicklers. We have 
already seen that it is not agreed whether all 
homozygous sicklers develop the anaemia in 
Africa; but no one doubts that some of them 
do. Even if only a proportion of these children 
died in infancy or otherwise failed to reproduce, 
there would be a very considerable loss of 
sickling genes in each generation. Thus the 
frequency of sickling in populations might be 
expected to decline from generation to genera­
tion until it died out altogether. The sickle-cell 
gene has apparently existed in Africa for cen­
turies without dying out. What mechanism 
compensates for the loss of homozygous sicklers?
There are several possible explanations of 
this phenomenon. At least one author33 has 
suggested that the genes are replaced by muta­
tion—-that is. by the appearance de novo of 
sickling genes in the chromosomes of normal 
individuals. This would mean, however, that 
the mutation rate would have to be different 
in every tribe of different sickling incidence, 
and in high-incidence tribes the rate would be 
indeed incredible. It seems more probable that 
the key to the problem lies with the bearers of 
the trait; that is, with the heterozygotes. If 
trait-bearers were to enjoy a small advantage 
in health or fertility over normal non-sickling 
subjects, this might compensate for the loss of 
homozygous sicklers because of the fact that the 
heterozygotes are far more numerous. In other 
words, a balanced polymorphism would be set 
up. This question hinges on the health of 
trait-bearers.
In the earlier days of sickling investigations, 
many workers held that the sickle-cell trail was 
itself a cause of morbidity. These opinions were 
based more on clinical impressions than on 
statistics, and it has become clear with the 
passage of time that trait-bearers are not more 
liable to disease, generally speaking, than are 
normal people. To me at any rate it seems very 
doubtful whether intravascular sickling of red 
cells ever occurs to a significant degree in true
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trait-bearers, i.e.. in heterozygotes, except dur­
ing aeroplane flights at high altitudes.34-35 I 
think it very likely that the vascular phenomena 
in sickling, like the anaemia, are the prerogative 
of homozygous sicklers.36
If it is true that trait-bearers are not un­
healthy by comparison with normal subjects, 
this is indeed what would be expected on bio­
logical grounds, since if it were not so the 
survival of the gene would be very hard to 
explain. But to account for this survival the 
trait-bearer should in fact be favoured  by 
selection. In 1949 Raper37 had tentatively 
suggested that sickling might protect against 
tropical parasites, though he regarded it as 
unlikely. Beet23 and myself17 had observed 
that trait-bearers in Rhodesia had a lower inci­
dence of palpable spleens than non-sicklers. and 
I suggested3,1 that the abnormal haemoglobin 
in sicklers might offer an unfavourable environ­
ment for plasmodia and that the sickler might 
thus be favoured by having a high resistance 
to malaria. This was conjecture, but Allison 
was then already working on the same lines 
and has produced some more convincing evi­
dence.3'1 He exposed sickling and non-sickling 
volunteers to malaria and found that the trait- 
bearers appeared to have a considerably higher 
resistance to infection with the parasite than 
normal subjects. It seems probable that in­
creased resistance to malaria is at least one of 
the mechanisms by which selection favours the 
heterozygous sickler. This view gains support 
from the fact that sickling is seen at highest 
frequencies in some of the most malarious areas 
of Africa. Where there is no malaria the selec­
tive disadvantage of homozygosity might well 
prevent the establishment of the gene.
Despite the apparent fact that sickling is most 
common in malarious areas, it is clear that 
malaria will not account fully for its distribution 
in Africa. For example, the gene is rare south 
of the Zambesi River, although malaria is not. 
1 think that this is simply because the compara­
tively recent migration that brought the gene 
to Africa did not spread further south than the 
Zambesi River. Thus the distribution of sickling 
is still of great anthropological interest. All 
over Africa the tribal groups are breaking up. 
and what work is to be done on the distribution 
of sickling will have to be done soon. There 
are large gaps in our knowledge. From North­
ern Rhodesia I know of no sickling investiga­
tions since the impressive work of Beet, who is 
no longer in the colony. The only studies of 
Nvasaland tribes known to me are my own, and
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as these were clone on emigrant miners in 
Southern Rhodesia they may well not be repre­
sentative. In Southern Rhodesia little is known 
about the more northern tribes, such as the 
Shona-speaking Zezuru and Korekore and the 
Tonga of the north-west. The technique of 
sickling surveys is simple and they need not 
take up much time, and it would be most gratify­
ing if medical officers in the Federation could 
contribute to our still very inadequate know­
ledge of sickle-cell distribution.
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Chewa, Sengrt, Angoni,  Tumbuka :  Beet ( 2 3 1 ,
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